Innovative Journal of Pediatrics
The Scientific Journal of Growth & Development Research Center
Image Credit:Inn J Pediatr
Outline
Platelets in Pulmonary Hypertension: a Causative Role or a Simple Association?
Authors
Abstract
Pathophysiology of pulmonary arterial hypertension is based on three basic mechanisms: thrombotic pulmonary vascular lesions, vasoconstriction and vascular remodeling. Platelets are related to all of these mechanisms by their aggregation, production, storage and release of several mediators. The role of platelets is more prominent in some types of pulmonary arterial hypertension, including those which are secondary to inflammatory and infectious diseases, hemoglobinopathies, essential thrombocythemia, drugs, thrombo-embolism, and cardiac surgery. Most pulmonary antihypertensive drugs have a negative effect on platelets. In this review, the mechanisms of platelets association with pulmonary arterial hypertension, those types of pulmonary arterial hypertension with greatest platelet contribution to their pathophysiology, and the effects of pulmonary antihypertensive drugs on platelets are summarized.
Highlights
References
- 1.References are available in PDF.
Copyright
© 2015, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Pulmonary Arterial Hypertension
Mortezaeian H. Pulmonary Arterial Hypertension. Multidiscip Cardio Annal. 2007;1(4):e8682. doi:
Evaluation of the Correlation of Pulmonary Arterial Hypertension (PAH) with the Pulmonary Artery Trunk Diameter and Serum Level of N-Terminal Pro B-Type Natriuretic Peptide (NT-proBNP) in Patients with PAH
Gharibi S, Ghavami M, Khederlou H, Ghorashi SM, Dabiran S, et al. Evaluation of the Correlation of Pulmonary Arterial Hypertension (PAH) with the Pulmonary Artery Trunk Diameter and Serum Level of N-Terminal Pro B-Type Natriuretic Peptide (NT-proBNP) in Patients with PAH. I J Radiol. 2023;20(2):e133022. doi: https://doi.org/10.5812/iranjradiol-133022
Safety of Adenosine for Acute Pulmonary Vasoreactivity Testing in Pulmonary Hypertension
Amin A, Navid H, Chitsazan M, Ghaleshi B, Taghavi S, et al. Safety of Adenosine for Acute Pulmonary Vasoreactivity Testing in Pulmonary Hypertension. Multidiscip Cardio Annal. 2016;7(1):e9324. doi: https://doi.org/10.17795/mcardia.9324
Clinical and Paraclinical Findings of Primary Pulmonary Hypertension in Children
Mottaghi Moghaddam Shahri H, Ghofrani M, Alizadeh B, Seyedi J, Heidari E. Clinical and Paraclinical Findings of Primary Pulmonary Hypertension in Children. Multidiscip Cardio Annal. 2023;14(1):e114419. doi: https://doi.org/10.5812/mca-114419
Evaluation of the relationship between WBC, HS.CRP and secondary pulmonary hypertension in patients with COPD
Ansarin K, Rashidi F, Ghaffari MR, Namdar H, Sharifi A. Evaluation of the relationship between WBC, HS.CRP and secondary pulmonary hypertension in patients with COPD. J Kermanshah Univ Med Sci. 2014;17(10):e74331. doi: https://doi.org/10.22110/jkums.v17i10.1213
- Scopus by DOI: 0
Last Update: 2 weeks ago
- Scopus by Title: 0
Last Update: 2 weeks ago
- Scopus by Title (Ref): 23
Last Update: 2 weeks ago
- CrossRef: 0
Last Update: 3 hours ago
- OpenAlex: 0
Last Update: 6 hours ago
- OpenCitations: 0
Last Update: 5 days ago